Page 118 - Canine Lameness
P. 118
90 6 The Myofascial Examination
with a comorbid issue(s). In primary MPS, the localization of pain and dysfunction causing lame-
ness will not be properly identified without a myofascial examination. As such, the diagnosis may
be missed and appropriate treatment may not be initiated. Secondary MPS is highly prevalent in
both people and dogs affected by any orthopedic condition or recovering from orthopedic and/or
neurologic surgeries as described above.
Many treatment options for MPS have been described (Gerwin 2016). For example, treatment
with dry needling has been shown to benefit patients with secondary MPS (Janssens 1991; Espejo‐
Antunez et al. 2017). It has also been successfully used to improve comfort after total knee arthro-
plasty in people (Mayoral et al. 2013). While there is still some controversy about the use in
veterinary medicine, a better understanding of the patterns of myalgia and dysfunction associated
secondary MPS may assist in localization of the primary issue as well as identification of additional
areas for therapeutic intervention.
It is important to understand that common imaging modalities (radiography as well as standard
ultrasound) are unable to diagnose MTPs. This in turn may place fault with a lesion that is not the
real etiology (but can be identified with these diagnostic means).
References
Alvarez, D.J. and Rockwell, P.G. (2002). Trigger points diagnosis and management. American Family
Physician 65 (4): 653–660.
Chen, Q., Wang, H.‐J., Gay, R.E. et al. (2016). Quantification of myofascial taut bands. Archives of
Physical Medicine and Rehabilitation 97 (1): 67–73.
Dommerholt, J. and Gerwin, R.D. (2015). A critical evaluation of Quintner et al.: missing the point.
Journal of Bodywork and Movement Therapies 19 (2): 193–204.
Espejo‐Antunez, L., Tejeda, J.F., Albornoz‐Cabello, M. et al. (2017). Dry needling in the management
of myofascial trigger points: a systematic review of randomized controlled trials. Complementary
Therapies in Medicine 33: 46–57.
Frank, E.M. (1999). Myofascial trigger point diagnostic criteria in the dog. Journal of Musculoskeletal
Pain 7 (1–2): 231–237.
Gerwin, R.D. (2010). Myofascial pain syndrome. In: Muscle Pain: Diagnosis and Treatment (eds.
S. Mense and R.D. Gerwin), 15–83. Berlin: Springer.
Gerwin, R.D. (2016). Myofascial trigger point pain syndromes. Seminars in Neurology 36 (5): 469–473.
Janssens, L.A. (1991). Trigger points in 48 dogs with myofascial pain syndromes. Veterinary Surgery 20
(4): 274–278.
Janssens, L.A. (1992). Trigger point therapy. Problems in Veterinary Medicine 4 (1): 117–124.
Lavelle, E.D., Lavelle, W., and Smith, H.S. (2007). Myofascial trigger points. Anesthesiology Clinics 25
(4): 841–851. vii–viii.
Mayoral, O., Salvat, I., Martin, M.T. et al. (2013). Efficacy of myofascial trigger point dry needling in
the prevention of pain after total knee arthroplasty: a randomized, double‐blinded, placebo‐
controlled trial. Evidence‐based Complementary and Alternative Medicine 2013: 694941.
Quintner, J.L., Bove, G.M., and Cohen, M.L. (2015). A critical evaluation of the trigger point
phenomenon. Rheumatology (Oxford) 54 (3): 392–399.
Shah, J.P. and Gilliams, E.A. (2008). Uncovering the biochemical milieu of myofascial trigger points
using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome.
Journal of Bodywork and Movement Therapies 12 (4): 371–384.